Physician profile
Mark E Manning
NPI 1437150208
$1,583.61
in general payments reported to CMS, 2019-2025
22 companies · $664 in 2025
The $664 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $252 · 2022: $278 · 2023: $273 · 2024: $117 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $919.44 |
| Education | $133.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $273.58 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $215.63 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $133.63 | 2022-2025 | Nucala |
| Acclarent, INC | $116.43 | 2021-2024 | Trudi Nav Cable, Acclarent Aera, Relieva Spinplus |
| Vertex Pharmaceuticals Incorporated | $110.54 | 2025 | |
| Aerin Medical INC. | $101.06 | 2025 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2025 | |
| Alk-Abello, INC | $73.82 | 2021-2023 | Timothy, Standardized, Alternaria Tenuis, Standardized Mite D. Farinae |
| Hologic Sales and Service, LLC | $70.64 | 2023 | Coolseal Generator |
| Inspire Medical Systems, INC. | $66.81 | 2024-2025 | Inspire |
| Amgen INC. | $51.97 | 2025 | Tezspire |
| Kaleo, INC. | $39.82 | 2021-2022 | |
| Intersect Ent, INC. | $37.87 | 2021 | |
| Apria Healthcare LLC | $31.03 | 2021 | |
| Integra Lifesciences Corporation | $30.11 | 2024-2025 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $28.33 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $25.59 | 2021 | |
| Medtronic, INC. | $17.11 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.24 | 2023 | |
| Paratek Pharmaceuticals, INC. | $16.18 | 2025 | Xhance |
| Ars Pharmaceuticals Operations, INC. | $13.82 | 2025 | Neffy |
| Optinose US, INC. | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Manning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.